Skip to Main Content

Paper Details

Patient-derived melanoma organoid models facilitate the assessment of immunotherapies.
EBioMedicine
7
2023
Anti-PD-1 antibodies, CD11b, CD14, CD15, CD3, CD4, CD8, CD8 T, CD8 T cells, CTLA-4, IL-2, MPDOs, Melanoma, Navitoclax, PD-1, PD-L1, Patient, Patient-derived melanoma organoid models, TIL, TILs, TIM-3, Treg, anti-PD-1 antibodies, collagen, immune cell, immune cells, lymphoid and myeloid lineages, melanoma, melanoma cell, melanoma cells, monocytic, myeloid cells, patient, patients, tumor, tumor infiltrating lymphocytes
Author NameAffiliation
Haiwei MouThe Wistar Institute
Meenhard HerlynThe Wistar Institute
  • 1 - 2

Datasets

Release 1.2